Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.

Loading...
Thumbnail Image

Embargo End Date

Authors

Went, M
Sud, A
Speedy, H
Sunter, NJ
Försti, A
Law, PJ
Johnson, DC
Mirabella, F
Holroyd, A
Li, N
Orlando, G
Weinhold, N
van Duin, M
Chen, B
Mitchell, JS
Mansouri, L
Juliusson, G
Smedby, KE
Jayne, S
Majid, A
Dearden, C
Allsup, DJ
Bailey, JR
Pratt, G
Pepper, C
Fegan, C
Rosenquist, R
Kuiper, R
Stephens, OW
Bertsch, U
Broderick, P
Einsele, H
Gregory, WM
Hillengass, J
Hoffmann, P
Jackson, GH
Jöckel, K-H
Nickel, J
Nöthen, MM
da Silva Filho, MI
Thomsen, H
Walker, BA
Broyl, A
Davies, FE
Hansson, M
Goldschmidt, H
Dyer, MJS
Kaiser, M
Sonneveld, P
Morgan, GJ
Hemminki, K
Nilsson, B
Catovsky, D
Allan, JM
Houlston, RS

Document Type

Journal Article

Date

2018-12-21

Date Accepted

2018-11-19

Date Available

Abstract

The clustering of different types of B-cell malignancies in families raises the possibility of shared aetiology. To examine this, we performed cross-trait linkage disequilibrium (LD)-score regression of multiple myeloma (MM) and chronic lymphocytic leukaemia (CLL) genome-wide association study (GWAS) data sets, totalling 11,734 cases and 29,468 controls. A significant genetic correlation between these two B-cell malignancies was shown (Rg = 0.4, P = 0.0046). Furthermore, four of the 45 known CLL risk loci were shown to associate with MM risk and five of the 23 known MM risk loci associate with CLL risk. By integrating eQTL, Hi-C and ChIP-seq data, we show that these pleiotropic risk loci are enriched for B-cell regulatory elements and implicate B-cell developmental genes. These data identify shared biological pathways influencing the development of CLL and, MM and further our understanding of the aetiological basis of these B-cell malignancies.

Citation

Blood cancer journal, 2018, 9 (1), pp. 1 - ?

Source Title

Publisher

NATURE PUBLISHING GROUP

ISSN

2044-5385

eISSN

2044-5385

Research Team

Cancer Genomics
Myeloma Group

Notes